Answers are grounded in this paper and cite their sources.
This is the first pan-Asian consensus for aesthetic use of botulinum toxin type A. Its unique objective is to optimize treatment safety and efficacy for patients of complete or part-Asian ancestry in all regions. The recommendations for incobotulinumtoxinA may be extended with care to other botulinum toxin formulations.
No takes yet. Share an insight, caveat, or question.
Sundaram et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: